Plain-English translation of NCT06934499 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research study that follows people with lung cancer at hospitals across Tunisia. Researchers will collect information about your diagnosis, the treatments you receive, and how you respond to those treatments over time. The goal is to understand lung cancer patterns and outcomes in Tunisia so doctors can improve care for future patients.
Lung cancer affects many people, and understanding how the disease progresses and which treatments work best in real-world settings helps doctors provide better, more personalized care. This study will give researchers important information about lung cancer in the Tunisian population specifically.
You likely qualify if…
You likely don't qualify if…
You will continue receiving your regular medical care at your hospital. Researchers will collect information from your medical records about your diagnosis, the treatments you receive, and how your condition changes over time. There are no special visits or procedures required beyond your normal cancer care appointments—the study simply involves sharing your existing medical information with the research team.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
Tunisia
The Multidisciplinary Consultation Meeting Thoracic Oncology of the Abderrahmen Mami Hospital (ROTHAM), Tunisian Society of Respiratory Diseases and Allergology
Enrollment target
~1,334 participants
Started
May 2025
Primary completion
October 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in June 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Soraya Fenniche, MD
Multidisciplinary consultation meeting Thoracic of the Abderrahmen Mami ROTHA Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.